ZC0101
ZC0101 is a potent, orally active IDO1 and TrxR dual inhibitor with IC50 values of 0.084 μM and 7.98 μM, respectively. ZC0101 effectively induces apoptosis and ROS accumulation in cancer cells[1].
Product Specifications
CAS Number
2541604-52-6
UNSPSC
12352005
Target
Apoptosis; Indoleamine 2,3-Dioxygenase (IDO) ; Reactive Oxygen Species (ROS)
Type
Reference compound
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/zc0101.html
Solubility
10 mM in DMSO
Smiles
O=C1C=CCCN1C(/C=C/C2=CC=CC=C2C3=CNC=N3)=O
Molecular Formula
C17H15N3O2
Molecular Weight
293.32
References & Citations
[1]Fan QZ, et al. Design, synthesis, and biological evaluation of a novel indoleamine 2,3-dioxigenase 1 (IDO1) and thioredoxin reductase (TrxR) dual inhibitor. Bioorg Chem. 2020 Dec;105:104401.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
IDO1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7026976-01 0.02 mg
Recombinant Saccharomyces cerevisiae Plasma membrane fusion protein PRM1 (PRM1)
Sign In for Pricing
View Details MBS7026976-02 0.1 mg
Recombinant Saccharomyces cerevisiae Plasma membrane fusion protein PRM1 (PRM1)
Sign In for Pricing
View Details MBS7026976-03 5x 0.1 mg
Recombinant Saccharomyces cerevisiae Plasma membrane fusion protein PRM1 (PRM1)
Sign In for Pricing
View Details 
